Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etrolizumab in moderate to severe ulcerative colitis
NCT01336465Phase 2Completed
- Sponsor
- Genentech
- Start
- Sep 2011
- Primary completion
- Sep 2012
- Countries
- 11
01
Overview
A Phase 2 trial of Etrolizumab in ulcerative colitis (UC), sponsored by Genentech. Started Sep 2011; status: completed.
02
Drugs
Etrolizumab
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01336465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01336465.